Two Sigma Investments’s C4 Therapeutics CCCC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.98M Buy
3,035,634
+1,526,031
+101% +$3.59M 0.01% 1582
2025
Q4
$2.88M Buy
1,509,603
+674,877
+81% +$1.6M ﹤0.01% 2166
2025
Q3
$1.85M Buy
834,726
+151,127
+22% +$363K ﹤0.01% 2180
2025
Q2
$978K Buy
683,599
+168,996
+33% +$246K ﹤0.01% 2266
2025
Q1
$823K Sell
514,603
-49,234
-9% -$147K ﹤0.01% 2287
2024
Q4
$2.03M Sell
563,837
-264,653
-32% -$1.32M ﹤0.01% 1703
2024
Q3
$4.72M Sell
828,490
-479,243
-37% -$2.88M 0.01% 1120
2024
Q2
$6.04M Buy
1,307,733
+135,893
+12% +$810K 0.01% 927
2024
Q1
$9.57M Buy
+1,171,840
New +$9.08M 0.02% 670
2023
Q4
Sell
-402,527
Closed -$749K 3170
2023
Q3
$749K Sell
402,527
-166,552
-29% -$508K ﹤0.01% 2088
2023
Q2
$1.56M Buy
569,079
+305,815
+116% +$983K ﹤0.01% 1654
2023
Q1
$827K Buy
263,264
+144,989
+123% +$854K ﹤0.01% 1966
2022
Q4
$698K Sell
118,275
-77,484
-40% -$642K ﹤0.01% 1874
2022
Q3
$1.72M Sell
195,759
-138,132
-41% -$1.43M 0.01% 1215
2022
Q2
$2.52M Buy
333,891
+218,960
+191% +$1.93M 0.01% 1065
2022
Q1
$2.79M Buy
+114,931
New +$2.79M 0.01% 1193
2021
Q4
Sell
-21,073
Closed -$942K 4327
2021
Q3
$942K Buy
21,073
+10,100
+92% +$433K ﹤0.01% 2672
2021
Q2
$415K Buy
+10,973
New +$393K ﹤0.01% 3250

Other funds holding CCCC